GPC3 and neoplasm: In this study, approximately similar specific T cell activation and tumor inhibitory effects were observed among mice immunized with PEG10 and GPC3 epitope or long peptide, placental gp96, and tumor lysate (see Figs. 4e–h, and 5a–d).